![Ulrich Blaschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Blaschke
Hoofd Techniek/Wetenschap/O&O bij
NYKODE THERAPEUTICS
Profiel
Ulrich Blaschke currently works at Eferest GmbH, as Chief Executive Officer and Nykode Therapeutics ASA, as Chief Technology Officer from 2024.
Dr. Blaschke received his doctorate degree from The Rockefeller University.
Actieve functies van Ulrich Blaschke
| Bedrijven | Functie | Begin |
|---|---|---|
| NYKODE THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Eferest GmbH
 Eferest GmbH Industrial MachineryProducer Manufacturing Manufactures pressure vessels and pressure-retaining parts | Algemeen Directeur | - |
Opleiding van Ulrich Blaschke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Eferest GmbH
Eferest GmbH Industrial MachineryProducer Manufacturing Manufactures pressure vessels and pressure-retaining parts | Producer Manufacturing |
